President Barack Obama and Japanese Prime Minister Shinzo Abe dine at Tokyo's 10-seat Sukiyabashi Jiro restaurant where the chef famously discourages chatting during the meal. Rough Cut (no reporter narration)
BASF SE (PNK:BASFY) Q1 2024 Earnings Call Transcript April 25, 2024 Stefanie Wettberg: Good morning, ladies and gentlemen. On behalf of BASF, I would like to welcome you to our conference call on the First Quarter 2024 Results. Throughout today’s recorded presentation, all participants will be in listen-only mode. The presentation will be followed by […]
These Grants follow the receipt of a New Hampshire grant PORTLAND, April 26, 2024 (GLOBE NEWSWIRE) -- Shorepower Technologies, Inc. (OTC PINK: SPEV) (“Shorepower”), following it becoming a public company through its merger last March and receipt of funds in connection with the merger, has focused on bolstering its internal infrastructure, grant writing capabilities and sales. Shorepower is now pleased to announce that it has received two state grants in California. The wins are for facilities ba
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ●First Quarter Revenues were $488,587, a 38% increase over the $352,799 reported in the first quarter of 2023. ●First Quarter Gross Profit was $2
The retail market in the United States stands as one of the most prominent and dynamic in the world, boasting key players such as Walmart among its ranks. As per our data, total retail sales in the United States surged to an impressive US$ 7.24 trillion in 2023. This substantial figure underscores the robust consumer demand and market vitality within the nation.NEWARK, Del, April 26, 2024 (GLOBE NEWSWIRE) -- The FMCG logistics market is on its way to marking a valuation of US$ 117.1 billion in 2
KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor conference call at 8:00 a.m. Eastern Time on Tuesday, April 30th, 2024. “We are very excited and look forward to sharing with our investors the growth that our company has seen over this last year,” stated Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. Please call the
ATLANTA, April 26, 2024--Manhattan wins Overall Innovation of the Year award by RetailTech Breakthrough for it's latest offering, Fulfillment Experience Insights.
$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)ALLO-316 Illustrates Proof-of-Concept in RCC and the Potential of Dagger® Technology to Optimize CAR T Cell Expansion and Persistence SOUTH SAN FRANCISCO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) produc
Boca Raton, Florida, April 26, 2024 (GLOBE NEWSWIRE) -- IB Acquisition Corp. (NASDAQ: IBACU) (the “Company”) announced today that, on May 1, 2024, the Company’s units will no longer trade, and that the Company’s common stock and rights, which together comprise the units will commence trading separately. The common stock and rights will be listed on the Nasdaq Global Market and trade with the ticker symbols “IBAC” and “IBACR”, respectively. This is a mandatory and automatic separation, and no act
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner Takeda (TSE:4502/NYSE:TAK) received notification that the Com
HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.
WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did
Partnering with Bare Knuckle (BKFC) for “Perry vs. Alves" PPV Event on Saturday, April 27, 2024 PPV Tickets Available for $29.99 at LiveOne.com LiveOne Continues to Dominate Live Streaming with Impressive Milestones: 252,268 PPV Tickets Sold200+ Million Viewers Reached5 Billion Engagements with Fans Across 220 Countries Highlighted PPV Events: Wiz Khalifa, MonsterX, Pitbull Social GlovesFloyd Mayweather vs. Logan PaulFloyd Mayweather vs. DejiIce Wars III: Outlaw EnforcersShowstar UK vs USA: Deji
OSAKA, Japan & CAMBRIDGE, Mass., April 26, 2024--Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when de
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the Board as a Class I Director. Dr. Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Prior to starting his career in the life science industry, he was an assistant professor of organic chemistry at the
IRVINE, Calif., April 26, 2024--CW Bancorp (OTCQX: CWBK), the parent company ("the Company") of CommerceWest Bank (the "Bank"), reported consolidated net income for the first quarter of 2024 of $2,993,000 or $0.96 per diluted share as compared to $4,618,000 or $1.37 per diluted share for the first quarter of 2023, an EPS decrease of 30%.
The Novera QPU Partner Program aims to enable high-performing, on-premises quantum computing by creating an ecosystem of quantum computing hardware, software, and service providers who build and offer integral components of a functional quantum computing system. Novera QPU customers can work with Novera QPU partners to build a quantum computer powered by the Novera QPU that satisfies their system requirements and quantum computing research objectives. BERKELEY, Calif., April 26, 2024 (GLOBE NEWS
CHARLOTTE, N.C., April 26, 2024--IPERIONX TITANIUM HAMR FURNACE INSTALLATION COMPLETE
Chicago, April 26, 2024 (GLOBE NEWSWIRE) -- Fill Finish Manufacturing market in terms of revenue was estimated to be worth $16.7 billion in 2024 and is poised to reach $25.7 billion by 2029, growing at a CAGR of 8.9% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. The major factors driving the growth of this fill finish manufacturing market include the increasing demand for biopharmaceuticals and vaccines. Additionally, advancements in technology such as automated
TEMPE, Ariz., April 26, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $150 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Al
Yahoo Finance